Be among the first to read our publication on "Regulatory Agilities in the time of #COVID-19" (pre-proof), which provides some analysis and examples of agilities adopted by #regulatoryauthorities during this pandemic. #flexibilities#regulatoryscience
Confinement strict, fermeture des écoles, soutien financier aux entreprises… Quelles mesures ont été prises à travers le monde pour faire face à la crise du #coronavirus ? 😷
Retrouvez toutes ces informations pour + de 9️⃣0️⃣ pays ici ➡️ https://t.co/bIct6KVRrn #COVID19
EMA’s human medicines committee (#CHMP) has started a ‘rolling review’ of data on the use of the investigational antiviral medicine #remdesivir for the treatment of #COVID19.
#coronavirus
👉https://t.co/7WqvyQXcXk
@EU_Commission has launched a joint 🌍 call for action to develop fast & equitable access to safe, effective and affordable diagnostics, therapeutics & vaccines against #COVID19.
Starting on 4️⃣ May 2020, the world becomes one #GlobalResponse.
#StrongerTogether
📢Healthcare professionals are recommended to closely monitor #COVID19 patients receiving #chloroquine or #hydroxychloroquine and to take into account pre-existing heart problems that can make patients more prone to heart rhythm issues:
👉https://t.co/mbFx7bQJ5z
#RealWorldEvidence is showing its value in tackling #COVID19, providing continuous insights on treatments' effectiveness. How can #RWD & #RWE help us deliver high quality and safe vaccines and treatments for patients? #RegulatoryRoadToInnovation https://t.co/zwzpDOsKXN
#SanofiActs
In this #COVID19 crisis, Sanofi stands ready to assist as many countries as possible by providing #hydroxychloroquine. If ongoing clinical studies demonstrate its efficacy and safety, Sanofi will continue to donate the medicine. https://t.co/6t8Vd95eVq
Supply of medicines is a critical concern for medicine regulators. What are the new measures taken by EU authorities to support availability of 💊💊 used in the #COVID19 pandemic? 📢Check out our communication: 👉https://t.co/pQjIwgdioU
A little reminder: there are still no treatments or cures for #coronavirus#FactsMatter: We all want an authorised treatment/vaccine to be available as soon as possible, but we also need them to be effective and safe for patients.
#COVID19
"As #COVID19 continues to spread, it is our job in the healthcare industry to do our part, which includes not only developing vaccines and treatments, but also keeping the public informed" Hear from Paul Hudson, our CEO, who shares Sanofi's commitment: https://t.co/XGK5KzB116
#WeWontRest: our members will continue to work around the clock to find new diagnostic tests, vaccines & treatments to help in the fight against #COVID2019
https://t.co/XeOEWPkl4A
What is the industry in Europe doing to help in the fight against the coronavirus? What is a vaccine? And how do they work? Check our #COVID19 Q&A https://t.co/gMUSjcn5LU #WeWontRest
Finding effective treatment for #patients with a #RareDisease can be difficult. EMA is committed to facilitating development of #OrphanMedicines to help diagnose and treat these patients: https://t.co/vE3DLaGpNY #RareDiseaseDay
Speaking to @ACANU_Geneva, I highlighted that the current #COVID19 outbreak is everyone's responsibility and requires solidarity, collaboration & innovative efforts. As #industry, we're committed to developing vaccines, therapies & diagnostics to contain the disease quickly.
🆕 We welcome today's @EUCourtPress ruling confirming public access to clinical study trials.
⚖️ judgement 👉 https://t.co/XZUCB4EfMU
We worked with @EMA_News over many years for greater transparency in this area 👇
https://t.co/RDvdy0ebff
https://t.co/WChXTx3aV2